Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano it
CORDIS - Risultati della ricerca dell’UE
CORDIS
Contenuto archiviato il 2024-05-30

Physiological function and potential therapeutic utility of the neuropeptide galanin in airway inflammation

Obiettivo

The results of studies of the physiological and pathophysiological effects of peptides have guided the development of two principal classes of therapeutic agents: small molecules able to block the action of peptide receptors and synthetic peptides mimicking the actions of endogenous molecules. Within this arena, the effects of neuropeptides on the central nervous system (CNS) have been studied intensively for more than 20 years, leading to several therapeutic products that are in clinical development. However, it is now clear, that the actions of neuropeptides are far more diverse than previously thought. Another area with great pharmacologic potential encompasses the peripheral actions of the neuropeptide galanin. Lately, galanin has been shown to exhibit potent anti-inflammatory action in the skin and recent data indicate that galanin is also involved in the physiology and the immune system of the airways. Consequently, we hypothesise that galanin is a crucial regulator of airway inflammation and vascular tone in the lung. We further propose that galanin exerts its effects at different cellular levels within the pulmonary system. The aim of this study is to determine novel/specific functions and sites of action of galanin in the respiratory system and to evaluate the therapeutic potential of galanin on airway inflammation and hyperreactivity. To achieve these specific aims we will take a multidisciplinary approach, employing molecular and cell biology, pharmacology, in vivo animal model and clinical research. The outcomes of this study will precisely define the role of galanin in the respiratory system and may suggest novel therapeutic strategies for the control of asthma, chronic bronchitis or other inflammatory pulmonary disorders. The findings from this research may also be relevant to the process of chronic inflammation in other organs, such as skin, joints and the gastrointestinal tract.

Campo scientifico (EuroSciVoc)

Argomento(i)

Invito a presentare proposte

FP7-PEOPLE-2010-IIF
Vedi altri progetti per questo bando

Meccanismo di finanziamento

MC-IIF - International Incoming Fellowships (IIF)

Coordinatore

GEMEINNUTZIGE SALZBURGER LANDESKLINIKEN BETRIEBSGESELLSCHAFT
Contributo UE
€ 175 844,80
Indirizzo
MULLNER HAUPTSTRASSE 48
5020 Salzburg
Austria
Regione
Westösterreich Salzburg Salzburg und Umgebung
Tipo di attività
Other
Collegamenti
Costo totale
Nessun dato